Mar 12, 20182 minAcesion Pharma Commences Phase 1 Study in Atrial FibrillationAcesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
Feb 8, 20182 minAcesion Pharma Receives Approval for Phase I Study in Atrial FibrillationAcesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
Nov 25, 20161 minAcesion Pharma has won the prize as EY Entrepreneur of the Year 2016 in lifescienceAcesion Pharma has won the prize as EY Entrepreneur of the Year 2016 among the nominated Danish Lifesciences companies. The award was...